1-4 of 4
Andreas Thiel, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD40L + CD8 + T-Cell Dependent Antitumor Immunity

Andreas Thiel, PhD, Marco Frentsch, Joanna Listopad, Regina Stark, Alberto Sada Japp, Nadine Matzmohr, Sarah Meier, Ichiro Taniuchi, MD PhD, Thomas Blankenstein, PhD
Journal: Blood
Blood (2014) 124 (21): 5818.
https://doi.org/10.1182/blood.V124.21.5818.5818
Published: 2014
Journal Articles

Inherent CD40L Expression Complements CD8 + T Cell Dependent Anti-Tumor Immunity

Andreas Thiel, PhD, Marco Frentsch, Regina Stark, Alberto Sada Japp, Joanna Listopad, Nadine Matzmohr, Sarah Meier, Dirk Busch, Axel Schulz, Thomas Blankenstein
Journal: Blood
Blood (2013) 122 (21): 4494.
https://doi.org/10.1182/blood.V122.21.4494.4494
Published: 2013
Journal Articles

Treatment of Adenovirus Infection by Adoptive Immunotherapy: Adenovirus Capsid Hexon Is the Main Target Protein of Adenovirus-Specific Cellular Immunity.

Olga Arbach, MD, Marco Frentsch, PhD, Barbara Chmielewicz, PhD, Marco Kaiser, PhD, Heinz Ellerbrock, PhD, Roland Lauster, PhD, Renate Arnold, MD, Andreas Radbruch, PhD, Sebastian Voigt, MD, Wolfram Ebell, MD, Andreas Thiel, PhD
Journal: Blood
Blood (2006) 108 (11): 2930.
https://doi.org/10.1182/blood.V108.11.2930.2930
Published: 2006
Journal Articles

Adenovirus Capsid Hexon Is the Main Target Protein of Adenovirus-Specific CD4 + T-Cells: Fundamentals for Targeting Adenovirus by Adoptive Immunotherapy.

Olga Arbach, MD, Marco Frentsch, Sebastian Voigt, MD, Barbara Chmielewicz, PhD, Marco Kaiser, Heins Ellerbrok, PhD, Roland Lauster, PhD, Andreas Radbruch, PhD, Alexander Scheffold, PhD, Wolfram Ebell, MD, Andreas Thiel, PhD
Journal: Blood
Blood (2005) 106 (11): 3034.
https://doi.org/10.1182/blood.V106.11.3034.3034
Published: 2005